Synapse - Christina Cho

Results (27)

Trial in progress: A first-in-human phase 1/2 study of hematopoietic stem cell transplantation (HCT) with VOR33 (CD33-deleted allograft) followed by treatment with gemtuzumab ozogamicin (GO) in patients with CD33+ acute myeloid leukemia (AML) who are at high-risk of post-HCT relapse

Meeting Abstract

Cooper, B. W.; Suh, H. C.; Koura, D.; Koehne, G.; Cho, C.; Bambace, N. M.; Bernard, L.; Shah, N. N.; Walter, R. B.; DiPersio, J. F.; more...
Blood (2022)

Fulltext@MSK | Save

Association of linguistic barriers and survival in allogeneic hematopoietic cell transplantation

Meeting Abstract

Walji, M.; Lee, J.; Devlin, S. M.; Gany, F.; Perales, M. A.; Giralt, S. A.; Cho, C.
Blood (2022)

Fulltext@MSK | Save

Allogeneic hematopoietic cell transplantation in patients with relapsed or refractory acute leukemia

Meeting Abstract

Elias, S.; Walji, M.; Brown, S.; Devlin, S. M.; Papadopoulos, E. B.; Jakubowski, A. A.; Ponce, D. M.; Young, J. W.; Giralt, S. A.; Perales, M. A.; more...
Blood (2022)

Fulltext@MSK | Save

Veno-occlusive disease risk and other outcomes in patients with B-cell precursor acute lymphoblastic leukemia who received inotuzumab ozogamicin and proceeded to hematopoietic stem cell transplantation: A registry-based, observational study

Meeting Abstract

De Lima, M. J. G.; Kebriaei, P.; Lanza, F.; Cho, C.; Popradi, G.; Hemmer, M. T.; Zhang, M. J.; Zhang, F.; Shah, R.; Welch, V.; more...
Blood (2022)

Fulltext@MSK | Save

Tracking immune reconstitution in the bone marrow following allogeneic hematopoietic transplantation in humans reveals early dominance of innate lymphoid populations

Meeting Abstract

DeWolf, S.; Kuttiyara, J.; Vinci, P.; Slingerland, J.; Marcello, L. T.; Giardina, P. A.; Donohoe, W.; Lin, R. J.; Papadopoulos, E. B.; Gyurkocza, B.; more...
Blood (2022)

Fulltext@MSK | Save

Prospective analysis to determine barriers to allogeneic hematopoietic cell transplantation in patients with newly diagnosed and relapsed acute leukemia

Meeting Abstract

Nath, K.; Lee, J.; Elko, T. A.; Levy, L.; Preston, E.; Devlin, S. M.; Ponce, D. M.; Lin, R. J.; Shaffer, B. C.; Cho, C.; more...
Blood (2022)

Fulltext@MSK | Save

Multicenter phase I study of post-transplant low-dose inotuzumab ozogamicin to prevent relapse of acute lymphoblastic leukemia

Meeting Abstract

Metheny, L.; Sobecks, R. M.; Cho, C.; Wang, J.; Ciarrone, L.; Caimi, P. F.; Otegbeye, F.; Cooper, B. W.; Gallogly, M.; Malek, E.; more...
Blood (2022)

Fulltext@MSK | Save

Analysis of 372 adult allograft recipients reveals associations between non-European ancestry, low socioeconomic status, and receipt of HLA-disparate grafts

Meeting Abstract

Fingrut, W.; Chinapen, S.; Katrichis, A.; Carino, C.; Davis, E.; Shaffer, B. C.; Cho, C.; Shah, G. L.; Barker, J. N.
Blood (2022)

Fulltext@MSK | Save

Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML

Journal Article

Murdock, H. M.; Kim, H. T.; Denlinger, N.; Vachhani, P.; Hambley, B.; Manning, B. S.; Gier, S.; Cho, C.; Tsai, H. K.; McCurdy, S.; more...
Blood (2022)

Fulltext@MSK | Save

Post-transplant inotuzumab ozogamicin for acute lymphoblastic leukemia

Meeting Abstract

Metheny, L. 3rd; Sobecks, R. M.; Cho, C.; Caimi, P. F.; Majhail, N. S.; Otegbeye, F.; Boughan, K. M.; Cooper, B. W.; Galloway, E.; Gallogly, M.; more...
Blood (2021)

Fulltext@MSK | Save